Alaunos Therapeutics (TCRT) Debt Ratio (2016 - 2023)

Alaunos Therapeutics has reported Debt Ratio for 4 years, with the latest figure at 0.23 in Q1 2023.

• For the quarter ending Q1 2023, Debt Ratio fell 21.04% year-over-year to 0.23; the trailing twelve-month figure through Mar 2023 stood at 0.23 (down 21.04% YoY), and the FY2022 full-year result was 0.26, up 1.55% from the prior year.
• Debt Ratio for Q1 2023 stood at 0.23, down from 0.26 in the prior quarter.
• The five-year high for Debt Ratio was 0.34 in Q3 2022, with the low at 0.21 in Q3 2021.
• Historically, Debt Ratio has averaged 0.27 across 3 years, with a median of 0.26 in 2022.
• Annual changes were most pronounced in 2022 — Debt Ratio jumped 58.16% — and 2023, when it decreased 21.04%.
• Alaunos Therapeutics' Debt Ratio stood at 0.25 in 2021, then gained by 1.55% to 0.26 in 2022, then slipped by 12.5% to 0.23 in 2023.
• The last three Debt Ratio figures came in at 0.23 (Q1 2023), 0.26 (Q4 2022), and 0.34 (Q3 2022), per Business Quant data.